{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,27]],"date-time":"2026-03-27T03:30:57Z","timestamp":1774582257211,"version":"3.50.1"},"reference-count":29,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.es","elsevier.es","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Actas Urol\u00f3gicas Espa\u00f1olas"],"published-print":{"date-parts":[[2021,5]]},"DOI":"10.1016\/j.acuro.2020.11.004","type":"journal-article","created":{"date-parts":[[2021,2,23]],"date-time":"2021-02-23T18:54:01Z","timestamp":1614106441000},"page":"264-272","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Angiomiolipoma renal y complejo esclerosis tuberosa: resultados a largo plazo en seguridad y eficacia de terapia con everolimus"],"prefix":"10.1016","volume":"45","author":[{"given":"E.","family":"Ruiz Guerrero","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.J.","family":"Ledo Cepero","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.V.","family":"Ojeda Claro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Soto Delgado","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.L.","family":"\u00c1lvarez-Ossorio Fern\u00e1ndez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.acuro.2020.11.004_bib0155","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1148\/radiographics.17.1.9017806","article-title":"Adult renal hamartomas","volume":"17","author":"Wagner","year":"1997","journal-title":"Radiographics."},{"key":"10.1016\/j.acuro.2020.11.004_bib0160","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1111\/j.1464-410X.2004.05046.x","article-title":"An epidemiological study of renal pathology in tuberous sclerosis complex","volume":"94","author":"O\u2019Callaghan","year":"2004","journal-title":"BJU Int."},{"key":"10.1016\/j.acuro.2020.11.004_bib0165","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1148\/radiol.2251011477","article-title":"Renal angiomyolipoma: relationships between tumor size, aneurysm formation, and rupture","volume":"225","author":"Yamakado","year":"2002","journal-title":"Radiology."},{"key":"10.1016\/j.acuro.2020.11.004_bib0170","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1016\/0092-8674(93)90618-Z","article-title":"Identification and characterization of the tuberous sclerosis gene on chromosome 16","volume":"75","year":"1993","journal-title":"Cell."},{"key":"10.1016\/j.acuro.2020.11.004_bib0175","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1053\/j.ajkd.2011.10.013","article-title":"Tuberous sclerosis complex-associated angiomyolipomas: focus on mTOR inhibition","volume":"59","author":"Budde","year":"2012","journal-title":"Am J Kidney Dis."},{"key":"10.1016\/j.acuro.2020.11.004_bib0180","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1016\/S0140-6736(12)61767-X","article-title":"Everolimus for angiomyolipoma associated with tuberous sclerosis complex or sporadic lymphangioleiomyomatosis (EXIST-2): a multicentre, randomised, double-blind, placebo-controlled trial","volume":"381","author":"Bissler","year":"2013","journal-title":"Lancet."},{"key":"10.1016\/j.acuro.2020.11.004_bib0185","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/j.pediatrneurol.2013.08.001","article-title":"Tuberous sclerosis complex diagnostic criteria update: recommendations of the 2012 Iinternational Tuberous Sclerosis Complex Consensus Conference","volume":"49","author":"Northrup","year":"2013","journal-title":"Pediatr Neurol."},{"key":"10.1016\/j.acuro.2020.11.004_bib0190","year":"2017","journal-title":"Common Terminology Criteria for Adverse Events (CTCAE) Version 5.0."},{"key":"10.1016\/j.acuro.2020.11.004_bib0195","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1016\/S0140-6736(08)61279-9","article-title":"Tuberous sclerosis","volume":"372","author":"Curatolo","year":"2008","journal-title":"Lancet."},{"key":"10.1016\/j.acuro.2020.11.004_bib0200","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1016\/j.jaad.2006.11.019","article-title":"Oral findings in 58 adults with tuberous sclerosis complex","volume":"56","author":"Sparling","year":"2007","journal-title":"J Am Acad Dermatol."},{"key":"10.1016\/j.acuro.2020.11.004_bib0205","doi-asserted-by":"crossref","first-page":"39","DOI":"10.4103\/2156-7514.83230","article-title":"Clinically relevant imaging in tuberous sclerosis","volume":"1","author":"Radhakrishnan","year":"2011","journal-title":"J Clin Imaging Sci."},{"key":"10.1016\/j.acuro.2020.11.004_bib0215","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1055\/s-0030-1269906","article-title":"Tuberous sclerosis complex: neurological, renal and pulmonary manifestations","volume":"41","author":"Franz","year":"2010","journal-title":"Neuropediatrics."},{"key":"10.1016\/j.acuro.2020.11.004_bib0220","doi-asserted-by":"crossref","first-page":"1777","DOI":"10.1038\/sj.ki.5001853","article-title":"Renal manifestations of tuberous sclerosis complex: Incidence, prognosis, and predictive factors","volume":"70","author":"Rakowski","year":"2006","journal-title":"Kidney Int."},{"key":"10.1016\/j.acuro.2020.11.004_bib0225","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1111\/j.1749-6632.1991.tb37754.x","article-title":"Epidemiology of tuberous sclerosis","volume":"615","author":"Osborne","year":"1991","journal-title":"Ann N Y Acad Sci."},{"key":"10.1016\/j.acuro.2020.11.004_bib0230","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1186\/s13023-016-0517-9","article-title":"Everolimus safety and efficacy for renal angiomyolipomas associated with tuberous sclerosis complex: a Spanish expanded access trial","volume":"11","author":"Robles","year":"2016","journal-title":"Orphanet J Rare Dis."},{"key":"10.1016\/j.acuro.2020.11.004_bib0235","doi-asserted-by":"crossref","first-page":"e15","DOI":"10.1159\/000320891","article-title":"Tuberous sclerosis complex renal disease","volume":"118","author":"Dixon","year":"2011","journal-title":"Nephron Exp Nephrol."},{"key":"10.1016\/j.acuro.2020.11.004_bib0240","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1016\/j.eururo.2008.04.025","article-title":"Renal angiomyolipoma: long-term results following selective arterial embolization","volume":"55","author":"Ramon","year":"2009","journal-title":"Eur Urol."},{"key":"10.1016\/j.acuro.2020.11.004_bib0245","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1053\/j.ajkd.2015.05.016","article-title":"Long-term follow-up assessing renal angiomyolipoma treatment patterns morbidity, and mortality: an observational study in tuberous sclerosis complex patients in the Netherlands","volume":"66","author":"Eijkemans","year":"2015","journal-title":"Am J Kidney Dis."},{"key":"10.1016\/j.acuro.2020.11.004_bib0250","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1002\/path.2289","article-title":"Constant allelic alteration on chromosome 16p (TSC2 gene) in perivascular epithelioid cell tumour (PEComa): genetic evidence for the relationship of PEComa with angiomyolipoma","volume":"214","author":"Pan","year":"2008","journal-title":"J Pathol."},{"key":"10.1016\/j.acuro.2020.11.004_bib0255","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/S0140-6736(12)61134-9","article-title":"Efficacy and safety of everolimus for subependymal giant cell astrocytomas associated with tuberous sclerosis complex (EXIST-1): a multicentre, randomised, placebo-controlled phase 3 trial","volume":"381","author":"Franz","year":"2013","journal-title":"Lancet."},{"key":"10.1016\/j.acuro.2020.11.004_bib0260","doi-asserted-by":"crossref","first-page":"e0180939","DOI":"10.1371\/journal.pone.0180939","article-title":"Everolimus long-term use in patients with tuberous sclerosis complex: Four-year update of the EXIST-2 study","volume":"12","author":"Bissler","year":"2017","journal-title":"PloS One."},{"key":"10.1016\/j.acuro.2020.11.004_bib0265","doi-asserted-by":"crossref","first-page":"e0201005","DOI":"10.1371\/journal.pone.0201005","article-title":"Angiomyolipoma rebound tumor growth after discontinuation of everolimus in patients with tuberous sclerosis complex or sporadic lymphangioleiomyomatosis","volume":"13","author":"Bissler","year":"2018","journal-title":"PloS One."},{"key":"10.1016\/j.acuro.2020.11.004_bib0270","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/j.pediatrneurol.2013.08.002","article-title":"Tuberous sclerosis complex surveillance and management: recommendations of the 2012 International Tuberous Sclerosis Complex Consensus Conference","volume":"49","author":"Krueger","year":"2013","journal-title":"Pediatr Neurol."},{"key":"10.1016\/j.acuro.2020.11.004_bib0275","author":"Ljungberg","year":"2020","journal-title":"European guidelines renal cell carcinoma"},{"key":"10.1016\/j.acuro.2020.11.004_bib0280","doi-asserted-by":"crossref","first-page":"F560","DOI":"10.1152\/ajprenal.00569.2013","article-title":"Evidence for pericyte origin of TSC-associated renal angiomyolipomas and implications for angiotensin receptor inhibition therapy","volume":"307","author":"Siroky","year":"2014","journal-title":"Am J Physiol Renal Physiol."},{"key":"10.1016\/j.acuro.2020.11.004_bib0285","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1093\/jjco\/hyr035","article-title":"Dramatic tumor response to everolimus for malignant epithelioid angiomyolipoma","volume":"41","author":"Shitara","year":"2011","journal-title":"Jpn J Clin Oncol."},{"key":"10.1016\/j.acuro.2020.11.004_bib0290","doi-asserted-by":"crossref","first-page":"e1099","DOI":"10.1016\/j.clgc.2019.07.005","article-title":"Application of everolimus in preoperative neoadjuvant therapy of tuberous sclerosis complex associated with renal angiomyolipoma: a single-center report of 5 cases","volume":"17","author":"Guo","year":"2019","journal-title":"Clin Genitourin Cancer."},{"key":"10.1016\/j.acuro.2020.11.004_bib0295","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1007\/s10147-017-1224-9","article-title":"Effect of everolimus treatment for renal angiomyolipoma with tuberous sclerosis complex: an evaluation based on tumor density","volume":"23","author":"Hatano","year":"2018","journal-title":"Int J Clin Oncol."},{"key":"10.1016\/j.acuro.2020.11.004_bib0300","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1016\/j.arbres.2012.02.002","article-title":"Reduction in size of renal angiomyolipoma after treatment with everolimus in lung transplantation due to lymphangioleiomyomatosis","volume":"48","author":"Bujalance-Cabrera","year":"2012","journal-title":"Arch Bronconeumol."}],"container-title":["Actas Urol\u00f3gicas Espa\u00f1olas"],"original-title":[],"language":"es","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0210480620302588?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0210480620302588?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T12:37:04Z","timestamp":1759322224000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0210480620302588"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,5]]},"references-count":29,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2021,5]]}},"alternative-id":["S0210480620302588"],"URL":"https:\/\/doi.org\/10.1016\/j.acuro.2020.11.004","relation":{},"ISSN":["0210-4806"],"issn-type":[{"value":"0210-4806","type":"print"}],"subject":[],"published":{"date-parts":[[2021,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Angiomiolipoma renal y complejo esclerosis tuberosa: resultados a largo plazo en seguridad y eficacia de terapia con everolimus","name":"articletitle","label":"Article Title"},{"value":"Actas Urol\u00f3gicas Espa\u00f1olas","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.acuro.2020.11.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 AEU. Published by Elsevier Espa\u00f1a, S.L.U. All rights reserved.","name":"copyright","label":"Copyright"}]}}